Literature DB >> 33768558

Emergency CABG for a migrated stent in a COVID-19 positive patient.

Juan F Parra1, Eric E Vinck2, Oscar Sánchez1, Andrés F Jiménez1, Federico Núñez1.   

Abstract

Percutaneous coronary interventions (PCI) have become a standard of treatment worldwide. Despite high safety rates, iatrogenic complications caused by stent dislodgements do exist in 0.21% of cases and most require emergency coronary artery by-pass grafting (CABG). Here we present a case of a coronavirus disease 2019 positive 40-year-old male patient presenting with STEMI due to thrombotic lesions in his left coronary trunk. The patient is taken to PCI and stent placement. Stent dislodgement results in the need for emergency CABG and stent removal. Informed consent and ethics approval were obtained.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; coronary artery by-pass grafting; stent migration

Mesh:

Year:  2021        PMID: 33768558      PMCID: PMC8251245          DOI: 10.1111/jocs.15523

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.778


Percutaneous coronary interventions (PCI) have become a standard of treatment worldwide. Despite high safety rates, iatrogenic complications caused by stent dislodgements do exist in 0.21% of cases and most require emergency coronary artery by‐pass grafting (CABG).1, 2 A 40‐year old coronavirus disease 2019 positive male patient presented with an extensive inferior lateral wall STEMI and RBBB to our institution. Echocardiogram revealed an inferior and apical wall hypokinesia with a left ventricular ejection fraction of 55%. Coronary angiogram was performed using a right radial artery access along with intravascular ultrasound revealing thrombotic lesions in the left coronary trunk and anterior descending artery in addition to atherosclerotic lesions. A medicated stent was deployed into the left coronary artery and directed towards the anterior descending artery. A post‐PCI angiographic computed tomography showed a dislodged left coronary stent into the aorta (Figure 1A). The patient was taken to an emergency CABG and stent retrieval using extracorporeal circulation and cardiac arrest. An aortotomy revealed the migrated coronary stent into the aortic lumen (Figure 1B). The dislodged stent was extracted from the left coronary ostium (Figure 1C,D) and the left internal mammary artery was grafted to the anterior descending artery and saphenous vein to the ramus intermedius. The patient had an adequate recovery and was discharged.
Figure 1

(A) Post‐PCI angiographic computed tomography showing a dislodged left coronary stent into the aorta. (B) An aortotomy revealed the migrated coronary stent into the aortic lumen. (C, D) The dislodged stent was extracted from the left coronary ostium. PCI, percutaneous coronary intervention

(A) Post‐PCI angiographic computed tomography showing a dislodged left coronary stent into the aorta. (B) An aortotomy revealed the migrated coronary stent into the aortic lumen. (C, D) The dislodged stent was extracted from the left coronary ostium. PCI, percutaneous coronary intervention

ETHICS STATEMENT

Ethics approval obtained.
  3 in total

1.  Surgical emergency due to coronary stent migration.

Authors:  Alessandro Castiglioni; Alessandro Verzini; Andrea Macchi; Ottavio Alfieri
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

2.  Coronary artery bypass as a treatment of stent dislodgement: A case report.

Authors:  Khalid S Ibrahim; Nizar R Alwaqfi; Rashid K Ibdah
Journal:  Ann Med Surg (Lond)       Date:  2019-10-01

3.  Emergency CABG for a migrated stent in a COVID-19 positive patient.

Authors:  Juan F Parra; Eric E Vinck; Oscar Sánchez; Andrés F Jiménez; Federico Núñez
Journal:  J Card Surg       Date:  2021-03-25       Impact factor: 1.778

  3 in total
  1 in total

1.  Emergency CABG for a migrated stent in a COVID-19 positive patient.

Authors:  Juan F Parra; Eric E Vinck; Oscar Sánchez; Andrés F Jiménez; Federico Núñez
Journal:  J Card Surg       Date:  2021-03-25       Impact factor: 1.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.